WILMINGTON, Del., Sept. 2, 2015 /PRNewswire/ -- Rigrodsky & Long, P.A.:

  • Do you own shares of Synergetics USA, Inc. (NASDAQ CM: SURG)?
  • Did you purchase any of your shares prior to September 2, 2015?
  • Do you think the proposed buyout price is too low?
  • Do you want to discuss your rights? 

Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of Synergetics USA, Inc. ("Synergetics" or the "Company") (NASDAQ CM: SURG) regarding possible breaches of fiduciary duties and other violations of law related to the Company's entry into an agreement to be acquired by Valeant Pharmaceuticals International, Inc. ("Valeant") (NYSE: VRX).

Click here to learn more: http://rigrodskylong.com/investigations/synergetics-usa-inc-surg.  

Under the terms of the agreement, shareholders of Synergetics will receive $6.50 per share in cash for each share of Synergetics they own.  In addition to the upfront cash payment, Synergetics stockholders will receive additional cash payments of up to $1.00 per share if specified sales milestones are achieved following the closing.

The investigation concerns whether Synergetics's board of directors failed to adequately shop the Company and obtain the best possible value for Synergetics's shareholders before entering into an agreement with Valeant.  According to Yahoo! Finance, at least one analyst has issued a price target for Synergetics's stock at $7.00 per share.     

If you own the common stock of Synergetics and purchased your shares before September 2, 2015, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Seth D. Rigrodsky or Gina M. Serra at Rigrodsky & Long, P.A., 2 Righter Parkway, Suite 120, Wilmington, DE 19803, by telephone at (888) 969-4242; by e-mail to info@rl-legal.com, or at: http://rigrodskylong.com/investigations/synergetics-usa-inc-surg.

Rigrodsky & Long, P.A., with offices in Wilmington, Delaware and Garden City, New York, regularly prosecutes securities class, derivative and direct actions, shareholder rights litigation and corporate governance litigation, on behalf of shareholders in states and federal courts throughout the United States.

Attorney advertising.  Prior results do not guarantee a similar outcome.

CONTACT:                                                                                              

Rigrodsky & Long, P.A.
Seth D. Rigrodsky
Gina M. Serra
(888) 969-4242
(302) 295-5310
Fax: (302) 654-7530
info@rl-legal.com 
http://www.rigrodskylong.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/synergetics-usa-inc-shareholder-alert-rigrodsky--long-pa-announces-investigation-of-buyout-300137318.html

SOURCE Rigrodsky & Long, P.A.

Copyright 2015 PR Newswire

Valeant Pharma (NYSE:VRX)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Valeant Pharma Charts.
Valeant Pharma (NYSE:VRX)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Valeant Pharma Charts.